Fact-checked by Grok 2 weeks ago

Wada test

The Wada test, also known as the intracarotid sodium amobarbital procedure (ISAP), is a specialized diagnostic examination designed to assess the functional dominance of each cerebral hemisphere for language and memory, primarily in patients with epilepsy who are candidates for resective brain surgery.^[1] Developed to minimize postoperative risks such as aphasia or amnesia, the test involves temporarily anesthetizing one side of the brain at a time through an injection of a short-acting barbiturate, allowing clinicians to evaluate cognitive functions while the patient remains awake.^[2] It remains a gold standard in preoperative epilepsy evaluation, despite emerging noninvasive alternatives like functional MRI.^[3] The procedure is typically conducted in a specialized neuroimaging suite by a multidisciplinary team, including an epileptologist, neuroradiologist, and neuropsychologist.^[1] It begins with catheter insertion into the femoral artery in the groin, followed by angiography to visualize cerebral blood vessels, after which amobarbital is injected into one internal carotid artery to sedate the corresponding hemisphere for about 10-15 minutes.^[2] During this period, the patient undergoes rapid assessments of speech comprehension, naming, repetition, and reading, as well as memory tasks using object recognition or story recall presented just before injection.^[1] The process is repeated for the contralateral side, with the entire test lasting 3-4 hours, often as an outpatient procedure requiring preparation such as fasting and avoidance of blood thinners.^[2] Originating in the late 1940s, the Wada test was pioneered by Japanese neurologist Juhn A. Wada (later a Canadian citizen) at Hokkaido University in Japan, who first reported its use in 1949 for localizing language areas in epilepsy patients through unilateral barbiturate injection.^[3] Building on earlier work with cortical anesthetics, Wada's innovation enabled safer preoperative mapping without invasive electrocorticography.^[3] In the 1960s, collaboration with neuropsychologist Brenda Milner at the Montreal Neurological Institute expanded the test to include memory evaluation, significantly improving predictions of surgical outcomes in temporal lobe epilepsy cases.^[3] Although risks are low—primarily temporary hemiparesis, headache, or rare vascular complications—the test's invasiveness has prompted its gradual replacement by advanced imaging in select patients, yet it retains utility in ambiguous or high-stakes scenarios.^[1]

Background and Purpose

Definition and Mechanism

The Wada test, also known as the intracarotid amobarbital procedure (IAP), is a diagnostic method that involves the injection of sodium amobarbital, a short-acting barbiturate, into the internal carotid artery to temporarily anesthetize one cerebral hemisphere for approximately 5-10 minutes.^[4] This procedure allows clinicians to isolate and evaluate the functional contributions of each hemisphere, particularly for language and memory, by observing the effects of unilateral inactivation.^[5] Originally developed for epilepsy evaluation, it simulates the impact of surgical resection on brain function.^[6] The mechanism of the Wada test relies on amobarbital's pharmacological action, which primarily enhances inhibitory neurotransmission at GABA_A receptors, leading to suppression of neuronal activity in the injected hemisphere.^[7] This results in reduced cerebral blood flow (hypoperfusion) and metabolic activity, particularly in medial temporal structures, causing temporary contralateral hemiplegia, aphasia if the dominant hemisphere is affected, and characteristic theta-delta patterns on electroencephalography (EEG).^[8] Injection into the internal carotid artery targets the anterior and middle cerebral artery territories, which supply the frontal, temporal, and parietal lobes, while sparing the posterior circulation supplied by the vertebral-basilar system to avoid broader brainstem effects.^[4] The anesthetic effect onset is rapid, occurring within seconds of the 75-125 mg bolus, enabling targeted assessment before recovery begins.^[9] Central to the test's utility are concepts of hemispheric dominance and contralateral function. In most right-handed individuals (approximately 95%), language is lateralized to the left hemisphere, while memory functions are often bilateral but with variable dominance; the Wada test reveals these asymmetries by demonstrating preserved or impaired performance when one side is inactivated.^[10] Contralateral motor effects, such as hemiparesis, confirm adequate hemispheric suppression, ensuring reliable evaluation of cognitive tasks from the intact side.^[8] This approach provides critical insights into functional organization without permanent damage.^[5]

Clinical Indications

The Wada test serves as a primary preoperative evaluation tool in epilepsy surgery, particularly for patients undergoing temporal lobectomy, where it confirms the lateralization of language and memory functions to predict potential postoperative deficits.^[11]^[12] It is indicated for individuals with drug-refractory epilepsy and a unilateral seizure focus, typically supported by normal imaging of the contralateral hemisphere and inconclusive results from noninvasive assessments such as functional MRI (fMRI).^[12] This evaluation helps determine the functional reserve in the unaffected hemisphere, guiding surgical decisions to minimize risks of aphasia or amnesia following resection.^[11] Secondary applications include assessment prior to brain tumor resection or other neurosurgical procedures that may compromise hemispheric function, such as in cases involving gliomas near eloquent areas like the inferior frontal or superior temporal gyri.^[13] The test is particularly valuable for evaluating atypical language dominance, which occurs more frequently in left-handed individuals (up to 30-40% atypical lateralization) or bilingual patients, where noninvasive methods may fail to accurately map hemispheric contributions.^[14]^[15] Patient selection emphasizes candidates with temporal lobe epilepsy who exhibit equivocal fMRI findings or bilateral language representation, ensuring the procedure addresses uncertainties in hemispheric specialization.^[12] As of 2025, the Wada test remains essential in scenarios where fMRI results are unreliable, though its overall use has declined with advances in imaging; surveys indicate it is performed in approximately 20-40% of epilepsy surgery centers, often limited to complex cases.^[14]^[16]

Procedure

Preparation

Prior to undergoing the Wada test, patients receive a comprehensive evaluation to ensure suitability and establish baseline function. This includes a detailed neurological examination to assess overall brain health and seizure history, often conducted by an epileptologist or neurologist.^[17] Angiography is performed beforehand to map cerebral vascular anatomy and confirm adequate blood flow to the brain regions of interest, typically involving catheter insertion via the groin and injection of contrast dye under X-ray guidance.^[1] Baseline cognitive testing, administered by a neuropsychologist, evaluates memory recall, language abilities, and intellectual function (such as IQ screening to exclude those with severe impairment, e.g., IQ below 70), providing a reference for intra-procedure assessments.^[2]^[1] The informed consent process is a critical step, where the multidisciplinary team—typically including a neurosurgeon, neuropsychologist, and neuroradiologist—explains the procedure in detail to the patient. This covers temporary effects like hemiparesis or confusion on the injected side, potential for seizures during the test, and rare risks of permanent neurological deficits or allergic reactions. Patients are encouraged to ask questions, and written consent is obtained only after full comprehension, emphasizing the test's role in guiding epilepsy surgery.^[17]^[18]^[2] Logistically, the Wada test is conducted in a specialized neurointerventional suite equipped for real-time monitoring, such as continuous EEG to track brain activity. The team present includes an interventional neuroradiologist for catheter management, a neuropsychologist for cognitive oversight, an epileptologist, nursing staff, and sometimes a speech-language pathologist to aid in language evaluation. Patients must fast for at least 8 hours prior (no food or drink after midnight, with morning medications allowed using sips of water), similar to requirements for cerebral angiography, to minimize risks during sedation. Screening for contraindications occurs during evaluation, focusing on allergies to contrast agents, anesthetics (e.g., barbiturates or iodine dyes), or conditions like severe vascular disease; medications such as aspirin or blood thinners are discontinued 1-2 weeks in advance. Bilateral testing is often performed sequentially on the same day or over separate sessions to allow recovery between injections. Patients arrive early (e.g., 15-30 minutes) with identification, insurance details, and a companion for transportation home, as the procedure spans 4-10 hours including preparation and observation.^[1]^[2]^[17]^[19]^[18]

Execution and Assessment

The execution of the Wada test begins with the insertion of a catheter via the femoral artery, which is advanced to the internal carotid artery supplying the hemisphere under evaluation.^[4] An angiogram is typically performed beforehand to map the vascular anatomy and confirm catheter placement.^[1] Once positioned, a bolus of 75-125 mg of sodium amobarbital is injected slowly over 5-10 seconds into the internal carotid artery, with additional incremental doses of 12.5 mg administered if needed to achieve adequate hemispheric inactivation.^[4] The injection is confirmed by the onset of contralateral hemiplegia (typically within 15-30 seconds) and EEG changes showing theta-delta slowing in the injected hemisphere, indicating successful anesthesia of the anterior two-thirds of the brain for approximately 5-10 minutes.^[4]^[20] Continuous video and EEG recording is maintained throughout to monitor patient responses, detect any seizures, and document behavioral changes.^[4]^[11] Assessment protocols commence immediately after confirmation of inactivation. Language testing, conducted within 1-2 minutes of injection while the hemisphere is anesthetized, evaluates dominance through tasks such as naming objects, reading sentences, and comprehending spoken or written commands.^[4] A scoring system quantifies deficits to calculate a laterality index based on percentage of correct responses across injections, with significant asymmetry (e.g., laterality index >50) indicating language dominance in the non-inactivated hemisphere.^[4] Memory evaluation follows, starting 2-5 minutes post-injection, to assess encoding and storage capabilities. Patients are presented with stimuli for story recall (e.g., narrating a short passage) and visual recognition (e.g., identifying objects or scenes from cards), which they must remember for later retrieval after the drug effects subside.^[4]^[1] Memory is scored based on recall performance by comparison to baseline and contralateral testing to determine hemispheric contribution.^[4] The process for each hemisphere lasts approximately 10-15 minutes, after which the patient recovers motor function.^[4] The contralateral hemisphere is then tested by repositioning the catheter, allowing at least 30 minutes for full recovery to avoid cumulative effects.^[4]^[11]

Recovery and Follow-Up

Following the Wada test, patients are transferred to a recovery unit for close monitoring, typically lasting 1 to 4 hours, to ensure resolution of temporary effects such as hemiparesis, fluctuations in vital signs, and any potential seizure activity.^[21]^[22] The induced contralateral hemiparesis, a normal response to the anesthetic injection, generally resolves within 15 to 30 minutes as the drug's effects dissipate, allowing for assessment of full neurological recovery.^[23] During this period, nursing staff frequently check the groin puncture site for bleeding or hematoma formation, monitor vital signs, and ensure the patient remains flat in bed with the affected leg straight to promote hemostasis.^[21]^[22] Patients are encouraged to drink fluids to flush the contrast dye and resume eating once alert, with most feeling back to baseline within 20 to 30 minutes post-procedure.^[21] If stable, patients are discharged the same day, usually after 4 to 6 hours of observation, with rare instances requiring overnight admission for persistent symptoms.^[2]^[22] Post-discharge instructions emphasize rest for 72 hours, limiting activity to light walking on the first day and avoiding driving for 48 hours or strenuous exertion to minimize complications at the access site.^[21] Patients must arrange for a driver home and monitor the groin area for signs of infection or bleeding, contacting their care team if issues arise.^[22] In follow-up, Wada test results are integrated with complementary data from modalities such as positron emission tomography (PET) and magnetoencephalography (MEG) to inform epilepsy surgery planning, particularly in localizing epileptogenic zones while preserving eloquent areas.^[24] Interpretation focuses on language and memory lateralization; for instance, bilateral language representation occurs in approximately 5% to 25% of epilepsy patients, influencing resection strategies to avoid global deficits.^[25] Memory asymmetry identified by the test guides the side of resection, as inadequate contralateral memory support predicts higher risk of postoperative verbal memory decline following temporal lobectomy, occurring in over 30% of cases with left-sided procedures.^[26] Patients receive counseling on these predicted deficits, including the potential for verbal memory loss, to weigh surgical benefits against risks.^[27] Re-testing may be required if clinical changes suggest shifts in hemispheric function due to neuroplasticity.^[28]

Risks and Limitations

Potential Complications

The Wada test, involving temporary hemispheric inactivation via intracarotid anesthetic injection, is associated with expected transient effects that are integral to its diagnostic purpose. Contralateral hemiparesis occurs in nearly all cases (approximately 100%) as the anesthetic disrupts motor function in the injected hemisphere, typically resolving within minutes to hours.^[29] Similarly, aphasia or confusion arises during dominant hemisphere inactivation in most patients, lasting 5-15 minutes and allowing assessment of language lateralization, while non-dominant injections may cause milder disorientation.^[30] Post-procedure headache and nausea are common mild effects, often attributable to contrast dye or catheter insertion, affecting up to 20-30% of patients but usually self-limiting within hours.^[1] Rare serious complications include stroke or embolism (0.6-1%), transient ischemic attacks (0.6%), induced seizures (1-2%), venous thrombosis, and infection at the catheter site.^[31] These events stem primarily from vascular access risks, such as embolism from catheter manipulation or anesthetic migration.^[31] Incidence is higher in patients with vascular anomalies, where rates may exceed 10% due to challenges in catheter placement.^[32] Overall complication rates range from 2-11% across studies, with no reported long-term morbidity or mortality in large cohorts; a 2015 review of 431 patients reported 2.1% clinical complications, lower than the 10.9% in a 2008 analysis of 677 cases.^[33]^[31] Recent data up to 2024 indicate persistent low incidence (<5% for serious events) when performed in experienced centers, though up to 10-30% of tests may yield unsatisfactory results due to transient side effects.^[34]^[35] Mitigation strategies include real-time fluoroscopy for precise catheter guidance and heparin flushing to prevent thrombosis, reducing vascular risks during the procedure.^[2]^[32] Immediate monitoring allows for rapid intervention, such as anticonvulsants for seizures, further minimizing adverse outcomes.^[33]

Contraindications and Patient Considerations

The Wada test carries relative contraindications in cases of severe atherosclerosis or carotid stenosis exceeding 70%, as the invasive catheterization risks dislodging atherosclerotic plaques and causing embolic events.^[36] Uncontrolled hypertension similarly requires careful management due to heightened vulnerability to cerebrovascular complications during arterial manipulation.^[36] Allergy to amobarbital, the primary anesthetic agent, is a contraindication requiring alternative agents to prevent adverse reactions.^[37] Relative contraindications encompass pregnancy, where potential fetal exposure to radiation and contrast agents must be weighed against benefits; bleeding disorders, including coagulopathy, which elevate hemorrhage risks at the catheter site; and recent stroke, as it may exacerbate ischemic vulnerabilities.^[38] Pediatric application is restricted by the requirement for patient cooperation and reliable communication, generally limiting use to those older than 8 years who can actively participate in cognitive assessments.^[1] Patient-specific considerations are essential to optimize safety and validity. For individuals with high anxiety, alternative sedation options—such as anxiolytics or propofol instead of amobarbital—can facilitate cooperation without compromising hemispheric inactivation.^[39] Non-native English speakers may require language-matched testing materials or interpreters to mitigate misinterpretation of aphasia-like deficits induced by the anesthetic.^[40] Ethical challenges in informed consent arise for patients with cognitive impairments, often necessitating involvement of legal guardians, simplified verbal explanations, or advance directives to ensure comprehension of procedural risks.^[41] Gender-based differences in Wada test outcomes are minimal, with similar language and memory lateralization patterns across sexes.^[10] However, left-handed individuals warrant cautious interpretation, as they exhibit higher rates of bilateral or atypical language dominance (approximately 15%), potentially leading to inconclusive results.^[10]

Alternatives and Advances

Non-Invasive Techniques

Functional magnetic resonance imaging (fMRI) serves as a primary non-invasive alternative to the Wada test, particularly for assessing language lateralization through activation tasks such as verb generation or semantic decision-making. These tasks elicit blood-oxygen-level-dependent (BOLD) signals in language-dominant regions, typically showing greater than 90% concordance with Wada test results in low-risk epilepsy patients without atypical language representation.^[42]^[43] However, fMRI's utility is limited for memory lateralization, where concordance rates drop to around 47% compared to the Wada test, due to challenges in capturing hippocampal activation reliably.^[16] The adoption of fMRI in epilepsy centers has grown substantially, with many institutions now using it routinely for preoperative language mapping, reflecting a shift toward safer, repeatable imaging.^[12] Magnetoencephalography (MEG) provides another non-invasive method for mapping eloquent cortex, measuring magnetic fields from neuronal currents to localize language and motor areas during tasks like auditory word recognition or picture naming. MEG excels in temporal resolution, identifying activation peaks in the superior temporal gyrus and inferior frontal gyrus with sensitivity comparable to invasive methods in select cases, and it avoids the spatial distortions of fMRI near air-tissue interfaces.^[44] For epilepsy patients, MEG aids in seizure onset zone identification and functional mapping, often integrated with MRI for source imaging to guide resection while preserving critical areas.^[45] Emerging hybrid approaches, such as MEG-fMRI combinations, enhance localization by leveraging MEG's timing precision with fMRI's spatial detail, improving language network delineation in complex cases.^[46] Less invasive variants of the Wada test, like superselective Wada using micro-catheters for targeted anesthetic injection into specific arterial branches, reduce systemic effects while assessing localized function, though they still involve catheterization.^[47] Despite these advances, non-invasive techniques have not fully supplanted the Wada test for high-stakes memory prediction in surgical planning, as they require validation in diverse patient populations.^[12]

Comparative Effectiveness

The Wada test serves as the historical gold standard for assessing hemispheric dominance of language and memory functions prior to epilepsy surgery, demonstrating near-perfect reliability (95-100%) in lateralizing language in patients with typical left-hemisphere dominance.^[12] Functional MRI (fMRI), a primary non-invasive alternative, shows 85-95% concordance with the Wada test for language lateralization, though discordance rises to 40% in cases of bilateral representation.^[48] For memory lateralization, fMRI concordance drops to approximately 79% in unilateral cases and as low as 47% overall, with false negatives occurring in 10-15% of temporal lobe epilepsy patients due to challenges in detecting subtle asymmetries.^[16] Electrocorticography (ECoG), while invasive and limited to intraoperative use, offers superior spatial resolution for localizing language areas, achieving 79% specificity compared to electrical stimulation mapping, surpassing the Wada test's broader hemispheric focus.^[49] Non-invasive methods like fMRI substantially improve safety profiles, with complication rates below 0.1% (essentially zero for routine imaging risks such as claustrophobia or contrast reactions), in contrast to the Wada test's 1-11% complication rate, including transient encephalopathy (7%), seizures (1%), and rare strokes (0.6-1.2%).^[12]^[50] Cost-effectiveness further favors fMRI, which incurred direct costs about one-third those of the Wada test (approximately $300 versus $1,130 per procedure as of 2004), making it preferable for routine presurgical evaluations in resource-limited settings.^[51] The Wada test retains applicability in 20-30% of complex cases where non-invasive results are discordant or fail to confirm bilateral independence, such as in atypical language dominance or when fMRI yields inconclusive memory data.^[48] According to the 2023 National Association of Epilepsy Centers (NAEC) guidelines (published 2024), the Wada test should be reserved for situations where non-invasive tests like fMRI or magnetoencephalography are inconclusive, emphasizing its selective use to balance risks and benefits.^[52] A trend toward "Wada-less" protocols has emerged, reflecting a decline from 81% utilization in 1997 to 14% by 2007 and continued reduction thereafter.^[53]

History and Development

Origins

The Wada test, also known as the intracarotid amobarbital procedure, was developed by Japanese neurologist Juhn Atsushi Wada in the late 1940s while he was working at Hokkaido Imperial University Hospital in Sapporo, Japan, shortly after obtaining his medical license in 1947.^[3] Wada, who had graduated from Hokkaido Imperial University in 1946 amid the challenges of postwar Japan, sought innovative methods to evaluate brain function in epilepsy patients during a time when diagnostic options were limited.^[54] His work built on earlier animal research, including his own experiments where unilateral intracarotid injection of the barbiturate amobarbital demonstrated the ability to anesthetize one cerebral hemisphere and prevent the bilateral propagation of seizures, providing a model for selective hemispheric inactivation without generalized effects.^[54] The initial rationale for the test stemmed from the need to reduce cognitive side effects of electroconvulsive therapy (ECT) for psychiatric disorders by temporarily anesthetizing the language-dominant hemisphere, allowing unilateral treatment.^[54] This approach was first applied clinically in 1949 to a patient experiencing prolonged focal motor status epilepticus, marking the inaugural human use of the procedure to evaluate hemispheric function in an epilepsy context.^[3]^[54] Wada's findings were published in 1949 in the Japanese journal Medicine and Biology, in a preliminary report titled "A new method for the determination of the side of cerebral speech dominance: A preliminary report on the intracarotid injection of sodium Amytal in man," which detailed the technique's utility for identifying language lateralization and laid the groundwork for its application in epilepsy surgery planning.^[3] Although developed in Japan, the test gained international recognition after Wada's 1954 sabbatical at the Montreal Neurological Institute, where he collaborated with neurosurgeon Wilder Penfield to refine and integrate it into preoperative evaluations for epilepsy surgery, adapting it further for memory assessment.^[54]

Evolution and Current Status

Following its initial development in the late 1940s, the Wada test underwent significant procedural refinements that established it as a cornerstone of epilepsy surgery evaluation. By the 1960s, it had become a standalone method for determining hemispheric dominance for language and memory, making it routine in preoperative assessments for temporal lobectomy.^[55]^[3] Further evolutions in the 1970s focused on dosage standardization to enhance safety and efficacy. Early applications varied widely in amobarbital amounts, but studies from this period refined protocols, increasing average doses from approximately 87 mg (1966–1970) to 110 mg thereafter, which improved consistent hemispheric inactivation while reducing systemic side effects like respiratory depression. By the 1990s, integration with advancing neuroimaging modalities, such as functional MRI (fMRI), began to complement the test; correlational studies demonstrated that fMRI language activation patterns aligned with Wada results in the frontal lobes, enabling hybrid approaches for more precise presurgical mapping.^[56]^[57]^[58] The test's role has notably declined in routine clinical practice over recent decades, reflecting the rise of non-invasive alternatives. In the 1990s, it was employed in about 85% of epilepsy surgery evaluations for language and memory lateralization, but usage has dropped to 20–30% by the 2020s, particularly in centers adopting fMRI and magnetoencephalography (MEG) for initial assessments. Despite this, the Wada test remains essential for validating results in ambiguous cases, such as those with atypical language representation or discordant noninvasive findings.^[59]^[60] As of 2025, the International League Against Epilepsy (ILAE) regards the Wada test as the invasive gold standard for functional lateralization, though guidelines recommend its selective use due to procedural risks, prioritizing it when noninvasive methods are inconclusive. Ongoing research emphasizes safer variants, including propofol-based intracarotid injections, which have demonstrated comparable efficacy to amobarbital with fewer adverse effects in pediatric and adult cohorts, and superselective IAP techniques that target specific arterial branches to minimize global hemispheric disruption. The passing of Juhn Wada in 2023 concluded the era of its originator's direct influence, yet the procedure endures as a benchmark in contemporary neurology for high-stakes epilepsy and tumor resections.^[52]^[61]^[62]^[63]^[64]

References

[1]
Wada Test: What It Is, Purpose, Procedure & Side Effects
The Wada test determines which side of your brain your language and memory abilities are located. It's a tool for people with epilepsy who may be candidates ...
[2]
Wada Testing | Johns Hopkins Medicine
The Wada test can help epilepsy doctors evaluate how important each side of the brain is with respect to language and memory functions. A “practice test ...What You Need To Know · Wada Test: Procedure · Part 2: Memory, Speech And...
[3]
[PDF] History of the Wada Test - Emory School of Medicine
This chapter discusses the origins and development of the Wada test. Wada ... a routine component of the preoperative evaluation for epilepsy surgery in the mid- ...<|control11|><|separator|>
[4]
Roles of fMRI and Wada tests in the presurgical evaluation of ... - NIH
Sep 30, 2022 · Wada test. The WT simulates the effects of brain surgery through the temporary inactivation of one hemisphere. This involves the use of short ...
[5]
Intracarotid Injection of Sodium Amytal for the Lateralization of ...
Intracarotid Injection of Sodium Amytal for the Lateralization of Cerebral Speech Dominance. Experimental and Clinical Observations. Juhn Wada.
[6]
Intracarotid injection of sodium amytal for the lateralization ... - PubMed
Intracarotid injection of sodium amytal for the lateralization of cerebral speech dominance. 1960. ... Authors. Juhn Wada , Theodore Rasmussen. Affiliation. 1 ...
[7]
Amobarbital - an overview | ScienceDirect Topics
4.1 Intracarotid sodium amobarbital procedure (WADA) test ... Barbiturates provide their mechanism of action by activating the inhibitory neurotransmitter GABA ...
[8]
Regional Cerebral Perfusion and Amytal Distribution ... - PubMed
... Wada test. Partial inactivation of memory structures is therefore a credible mechanism of action of the test. The double acquisition protocol provided no ...
[9]
Assessment of the Functional Effect of the Intracarotid Sodium ...
During the intracarotid amobarbital procedure, we measured delta activity in EEG recordings from implanted electrodes and regional cerebral blood flow (rCBF) ...
[10]
Mapping language dominance through the lens of the Wada test - NIH
The sodium amytal test, or “Wada test,” named after Juhn Wada, has remained a pillar of presurgical planning and is used to identify the laterality of the ...<|control11|><|separator|>
[11]
Wada Test Before Seizure Surgery - Epilepsy Foundation
Oct 14, 2018 · This test is officially known as the intracarotid sodium amobarbital procedure (ISAP), but the nickname "Wada test" is commonly used. The ...
[12]
Roles of fMRI and Wada tests in the presurgical evaluation of ...
The intracarotid amobarbital test, generally known as the Wada test (WT), has traditionally been used to determine language lateralization to estimate the risks ...Abstract · Introduction · Wada test · Discussion and conclusion
[13]
Roles of the Wada Test and Functional Magnetic Resonance ... - NIH
Dec 15, 2016 · Patients in whom we should apply the Wada test are those with tumors in the left hemisphere who present with right-hemisphere language dominance ...Missing: indications | Show results with:indications
[14]
Clinical practice of language fMRI in epilepsy centers: a European ...
Mar 13, 2020 · Clinical practice of language fMRI in epilepsy centers: a European survey and conclusions by the ESNR Epilepsy Working Group ... The Wada test has ...
[15]
Functional MRI study of language organization in left-handed and ...
Aug 5, 2020 · The left-handers present more frequent atypical language ... Mapping language dominance through the lens of the Wada test. Neurosurg. Focus ...
[16]
Concordance between fMRI and Wada test for memory lateralization ...
Only approximately 12% of the epilepsy centers indicated that they used the Wada test in every patient to assess preoperative memory function and language ...<|control11|><|separator|>
[17]
[PDF] Wada Testing - Northwestern Medicine
After the doctor has answered your questions, you will be asked to give your written consent for the test. Before the test is done, the doctor will perform a ...
[18]
Wada Testing - About, Procedure, Recovery - Penn Medicine
The Wada test is a neurological exam used to diagnose and treat epilepsy. It's often used to treat seizures that require surgery.How The Wada Test Works · A Leader In Seizure... · Our Doctors
[19]
Preparing for the Wada Test - Cottage Epilepsy Center
You'll spend approximately 8-10 hours at the hospital. This includes pre-procedure testing and recovery. Please arrange for transportation home.Missing: evaluation informed setup
[20]
The Wada test in the evaluation for epilepsy surgery - PubMed
The Wada test is the standard part of the pre-operative evaluation for epilepsy surgery. The procedure involves the slow injection of sodium amobarbital.
[21]
Video EEG Monitoring Epilepsy Testing
Wada Test · After discharge, take it easy for the next 72 hours. · DAY #1 (the day after your procedure): You may start to increase your walking, but only minimal ...
[22]
What to Expect After Wada Test - Cottage Epilepsy Center
You will be asked to stay 4-6 hours in the recovery area. Please have someone drive you home after you are discharged.Missing: monitoring | Show results with:monitoring
[23]
Wada Test - Neupsy Key
Mar 12, 2017 · Within 15 to 20 minutes, all testing items are presented, and simultaneously the contralateral hemiparesis usually resolves and ipsilateral ...
[24]
Tests Before Surgery for Seizures | Epilepsy Foundation
Oct 15, 2018 · Imaging during this phase may include fMRI, PET, SPECT, or MEG studies. Neuropsychology testing assesses language, memory, and cognition. A ...
[25]
Cortical Stimulation Mapping and Wada Results Demonstrate a ...
These studies have estimated bilateral language representation to range from 5 to 25% in this population. Variability in reported prevalence rates is ...
[26]
Use of Preoperative Functional MRI to Predict Verbal Memory ... - NIH
Verbal memory decline occurred in over 30% of patients. Good preoperative performance, late age at onset of epilepsy, left dominance on fMRI, and left dominance ...
[27]
Wada memory asymmetries predict verbal memory decline after ...
We conclude that Wada memory asymmetries provide one measure of the risk to material-specific decline in verbal memory after left ATL.Missing: loss | Show results with:loss
[28]
REPEATING-THE-WADA-TEST--HOW-OFTEN
Dec 3, 2005 · We reviewed all Wada tests performed by a single epileptologist over a 6 year period, and identified patients who had more than one Wada test.Missing: validity | Show results with:validity
[29]
Tolerability of propofol in Wada testing - PMC - NIH
Once PF was injected, we noticed weakness of the contralateral side and aphasia if the involved hemisphere were the dominant one in which the patient ...
[30]
Evaluation of adverse effects in intracarotid propofol injection for ...
Aug 6, 2025 · The authors evaluated adverse effects of intracarotid propofol injection during a Wada test and their risk factors in 58 patients.
[31]
Complications during the Wada test - PubMed
Complications were observed in 74 patients (10.9%) and included encephalopathy (7.2%), seizures (1.2%), strokes (0.6%), transient ischemic attacks (0.6%).Missing: incidence rates<|control11|><|separator|>
[32]
[PDF] Presurgical Evaluation of Patients With Epilepsy: The Wada Test
Jun 21, 2022 · One case series documented an overall complication rate of 10.9%.14 Neurologic complications include seizure, intracranial vessel injury ...
[33]
One center's experience with complications during the Wada test
Jun 4, 2015 · [1-3] One reason is that the Wada test is invasive, as it requires the insertion of a catheter into the internal carotid artery (ICA). The ...Missing: text | Show results with:text
[34]
Assessment of language lateralization in epilepsy patients using the ...
Feb 10, 2024 · In the cWada, adverse effects are observed in 10–30% of trials, hindering accurate assessments. In this study, we assessed the effectiveness of ...
[35]
Hydrophilic polymer embolism identified in brain tumor specimens ...
Sep 2, 2021 · [16],[17] The complication rate for Wada testing is likely around 2%, although some studies have reported up to 10%.
[36]
Quality Improvement Guidelines for Adult Diagnostic ...
Relative contraindications include iodinated contrast media allergy, hypotension, severe hypertension, coagulopathy, renal insufficiency, and congestive heart ...
[37]
https://www.epilepsysco.org/about-epilepsy/testing/wada-test/
[38]
Diagnostic cerebral angiography and the Wada test in pediatric ...
Specific aspects of performing the Wada test in the pediatric setting, anatomic considerations and contraindications, and the relevance of the Wada test in ...
[39]
When to Operate in Carotid Artery Disease - AAFP
Jan 15, 2000 · The procedure is indicated in symptomatic patients with carotid-territory transient ischemic attacks or minor strokes who have carotid artery stenosis of 70 to ...
[40]
FMRI Is a Valid Noninvasive Alternative to Wada Testing - PMC
Recent studies suggest that fMRI provides a valid noninvasive alternative to the Wada test for most patients. Although the focus of this review is on ...
[41]
Is Functional MR Imaging Assessment of Hemispheric Language ...
A structured Medline search was conducted to identify all studies that compared functional MR imaging with the Wada test for determining hemispheric language ...
[42]
a noninvasive alternative to the Wada procedure in
This study method may be substituted for the Wada procedure in assessing hemispheric dominance for language in select cases.
[43]
Presurgical Functional Cortical Mapping Using Electromagnetic ...
This review aims at providing a general overview of magnetoencephalography (MEG) and high-density electroencephalography (hdEEG) based methods and their ...Functional Cortical Mapping... · Eeg/meg Functional Cortical... · Motor Cortex Mapping
[44]
CONCORDANCE-OF-fMRI-AND-MEG-FOR-PRESURGICAL ...
Dec 3, 2005 · This study examines the concordance of fMRI and MEG for language lateralization in children with epilepsy. Functional MRI and MEG were performed ...
[45]
Determination of language areas in patients with epilepsy using the ...
We developed “ssWada,” which is a method for assessing the distribution of language areas, by refining the Wada test with advanced microcatheter technique. In ...
[46]
Language Lateralization by fMRI and Wada Testing in 229 Epilepsy ...
However, a more recent survey revealed a trend among epilepsy centers over the past 15 years to replace the standard Wada test with fMRI for the assessment of ...
[47]
ECoG high-gamma modulation versus electrical stimulation for ...
This meta-analysis showed that ECoG HGM is a specific (0.79, 95% CI 0.68, 0.88) but not sensitive (0.61, 95% CI 0.44, 0.76) modality for language localization ...
[48]
Complications during the Wada test - ScienceDirect.com
Of the 677 patients, 74 were affected by complications (10.9%). Two separate complications were seen in five patients (three patients with encephalopathy after ...
[49]
Functional MR Imaging versus Wada Test for Evaluation of ...
Jan 1, 2004 · RESULTS: The total direct costs of the Wada test ($1,130.01 ± $138.40) and of functional MR imaging ($301.82 ± $10.65) were significantly ...
[50]
Guidelines for Specialized Epilepsy Centers - Neurology.org
Feb 2, 2024 · The Wada test, the intracarotid administration of sedative to anesthetize 1 hemisphere, is also used to lateralize language and memory and is ...
[51]
Incidence and clinical decision making for the Wada test over one ...
Left temporal resection was performed in 55% of cases. The most frequent pathological diagnoses were hippocampal sclerosis (42%) and non-specific gliosis (26%).Missing: rates | Show results with:rates
[52]
Juhn A. Wada, MD (1924–2023) - PMC - NIH
Sep 12, 2023 · Intracarotid amobarbital administration was developed to reduce the cognitive side effects of electroconvulsive therapy (ECT) by anesthetizing ...Missing: definition | Show results with:definition
[53]
Intracarotid amobarbital procedure. The Wada test - PubMed
Wada testing has been a standard part of temporal lobectomy evaluation since the early 1960s. Although the procedure was initially used to lateralize ...
[54]
Amobarbital Effects and Lateralized Brain Function
The mechanism of the initial period of mutism and/or inattention is poorly understood. ... Validity of intracarotid sodium amobarbital (Wada test) for evaluation ...
[55]
Functional MR evaluation of temporal and frontal language ...
Conclusions: There was a good congruence between hemispheric dominance for language as assessed with the Wada test and fMRI laterality indices in the frontal ...Methods · Fmri Analysis · Discussion
[56]
The Wada Test: Current Perspectives and Applications
The Wada test has been an integral part of the preoperative evaluation for epilepsysurgery since the 1950s. Originally designed to establish cerebral ...
[57]
Beyond the Wada: An updated approach to pre-surgical language ...
The Wada test is considered the “gold standard” for lateralizing language dominance in the pre-surgical evaluation of epilepsy patients.
[58]
Incidence and clinical decision making for the Wada test over one ...
Aug 6, 2025 · Objective: The use of amobarbital in the Wada test varied between epilepsy centers, with no unified dosing or protocols available in the ...
[59]
Juhn Wada - 1924 - 2023 // International League Against Epilepsy
This procedure, which became known as the Wada test, was further refined to assess memory during his time at the MNI and became the gold standard to assess ...Missing: 1948 | Show results with:1948
[60]
The Safety and Efficacy of Propofol as a Replacement for ... - PubMed
These findings support previous studies indicating that propofol is as safe and efficacious as amobarbital, and can continue to be used in Wada procedures ...Missing: superselective IAP
[61]
Feasibility of the Superselective Test with Propofol for Determining ...
The use of propofol to perform the superselective test during brain AVM embolization is a safe and effective alternative to amobarbital.Missing: IAP | Show results with:IAP
[62]
Dr Juhn Atsushi Wada, 1924–2023 | British Columbia Medical Journal
Jun 5, 2023 · ... passed away peacefully at his home in Vancouver on 23 April. He had just celebrated his 99th birthday. Dr Wada was a neurologist at UBC ...